You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 5, February 2, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Men's Health
 •Men's Health, Other
 •Neurology
 •Alzheimer Disease
 •Dementias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dementia and Testosterone Levels in Men

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Ms Rosario and colleagues1 shows a close association between Alzheimer disease (AD) and reproductive hormone levels. The finding that there were no differences in brain estrogen levels brings into question the long-standing hypothesis that men are less susceptible to AD because they continue to produce estrogen from androstenedione, a precursor of testosterone. While the sex steroids are undoubtedly important for brain function, they are controlled by a complex feedback loop that is made up of numerous other hormones including gonadotropin-releasing hormone, luteinizing hormone, follicle-stimulating hormone, inhibins, activins, and follistatin. Since there is an inverse relationship between serum concentrations of sex steroids and gonadotropins, effects ascribed to declines in estrogen or testosterone could equally well be a consequence of higher levels of gonadotropins. We previously reported that individuals with AD have increased luteinizing hormone in neurons susceptible to AD pathology,2 consistent with the current finding . . . [Full Text of this Article]

Richard L. Bowen, MD
Voyager Pharmaceutical Corporation
Raleigh, NC

Ralph N. Martins, PhD
The Sir James McCusker Alzheimer’s Disease Research Unit
Hollywood Private Hospital Centre for Aging and Alzheimer’s Disease
Nedlands, Western Australia

Christopher W. Gregory, PhD
Voyager Pharmaceutical Corporation

Mark A. Smith, PhD; Craig S. Atwood, PhD
csa@medicine.wisc.edu
Institute of Pathology
Case Western Reserve University
Cleveland, Ohio



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.